Dapagliflozin Propanediol API

Therapeutic Category

Antidiabetic

Dose Form

Status

Commercialised

Available Regulatory Filing

DMF Avaialable

CAS No

960404-48-2

Pharmacopoeia

USP/In-House

Mechanism of Action

Dapagliflozin propanediol is an SGLT2 inhibitor that targets the sodium-glucose cotransporter 2 in the proximal renal tubules. By inhibiting SGLT2, it decreases glucose reabsorption from the tubular lumen, lowers the renal threshold for glucose, and promotes urinary glucose excretion, which helps to lower blood glucose levels in patients with type 2 diabetes.

Indication

Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, similar to the indication for Dapagliflozin.

Dapagliflozin API 

Dapagliflozin API  is a highly effective anti-diabetic active pharmaceutical ingredient that belongs to the SGLT2 inhibitor class. It is widely used in the treatment of Type 2 Diabetes Mellitus. Moreover, it helps control blood glucose levels by promoting the removal of excess glucose through urine.

Valence Labs stands as a reliable Dapagliflozin API manufacturer in India. We deliver high-quality, consistent, and regulatory-compliant API solutions to pharmaceutical companies worldwide. In addition, our advanced manufacturing processes ensure efficiency, precision, and scalability.


What is Dapagliflozin API?

Dapagliflozin API works as a potent SGLT2 inhibitor. Specifically, it blocks glucose reabsorption in the kidneys. As a result, the body removes excess glucose through urine, which helps reduce blood sugar levels effectively.

Furthermore, its proven safety and performance make Dapagliflozin API a preferred choice in modern anti-diabetic drug formulations.


Key Features of Dapagliflozin API

  • High purity and superior quality standards
  • GMP-compliant manufacturing facilities
  • Excellent stability for formulation development
  • Suitable for oral dosage forms
  • Consistent batch-to-batch quality
  • Reliable bulk supply for global markets

Additionally, our team tests every batch of Dapagliflozin API through strict quality control procedures. Therefore, we ensure safety, efficacy, and compliance at every stage.


Applications of Dapagliflozin API

Dapagliflozin API plays an important role in multiple therapeutic applications. For instance:

  • Treatment of Type 2 Diabetes Mellitus
  • Long-term blood glucose management
  • Combination therapies (such as with metformin)
  • Cardiovascular risk reduction

As a result, pharmaceutical companies increasingly prefer Dapagliflozin API for advanced anti-diabetic formulations.


Why Choose Us as Your Dapagliflozin API Supplier?

Valence Labs provides dependable solutions as a trusted Dapagliflozin API supplier. Not only do we focus on quality, but we also ensure consistency and customer satisfaction.

Our key advantages include:

  • Advanced manufacturing infrastructure
  • Experienced technical team
  • Regulatory support including DMF
  • Timely delivery and global export capability
  • Competitive pricing with premium quality

Moreover, we follow international standards throughout the production of Dapagliflozin API. Consequently, our clients receive reliable and compliant API solutions.


Global Demand for Dapagliflozin API

The demand for Dapagliflozin API continues to grow due to the rising number of diabetes cases worldwide. Therefore, pharmaceutical companies actively seek manufacturers that offer:

  • Consistent product quality
  • Strong regulatory compliance
  • Scalable and reliable supply chains

In this context, Valence Labs meets global expectations efficiently. As a result, we have become a trusted partner in the international API market.


Quality Assurance and Compliance

We prioritize quality at every stage of production. For example, our quality assurance system includes guidelines aligned with international standards set by the World Health Organization

  • Advanced analytical testing methods
  • In-house quality control laboratories
  • Comprehensive documentation support
  • Compliance with global quality standards

Additionally, we continuously monitor and improve our processes. Therefore, every batch of Dapagliflozin API meets strict industry requirements.


Phenylephrine API and Uraodeoxycholic Acid (UDCA API) are essential pharmaceutical ingredients used for different therapeutic purposes. Phenylephrine API helps relieve nasal congestion, while Uraodeoxycholic Acid (UDCA API) is widely used for liver and gallstone treatments, both ensuring high quality and effectiveness in formulations.

FAQ – Dapagliflozin API

Q1. What is Dapagliflozin API?
Dapagliflozin API is an anti-diabetic active pharmaceutical ingredient used to treat Type 2 diabetes.

Q2. How does Dapagliflozin API work?
It blocks glucose reabsorption in the kidneys and increases glucose excretion through urine.

Q3. Is Dapagliflozin API available in bulk?
Yes, manufacturers can purchase it in bulk quantities.

Q4. Do you provide regulatory documentation?
Yes, we provide DMF and other required documentation as applicable.

Q5. Where is Dapagliflozin API used?
It is used in anti-diabetic and combination drug formulations.